As of 2026-09-11, the Relative Valuation of Adverum Biotechnologies Inc (ADVM) is (81.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.36 USD, the upside of Adverum Biotechnologies Inc based on Relative Valuation is -1967.9%.
The range of the Relative Valuation is (75.83) - (93.48) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 23.3x | 21.1x |
| Forward P/E multiples | 15.6x - 23.4x | 19.5x |
| Fair Price | (75.83) - (93.48) | (81.44) |
| Upside | -1839.1% - -2244.0% | -1967.9% |
| Date | P/E |